February 11, 2013
CTI Clinical Trial and Consulting Services (CTI) will be one of the sponsors of the 8th Annual New York Stem Cell Summit, taking place February 19, 2013. The faculty will include more than 30 of the world’s leaders in this industry to lead discussions on investment opportunities, groundbreaking products, and the growing market potential in the stem cell marketplace.
Additionally, CTI President and CEO, Timothy J. Schroeder will present on the topic “Cutting Time to Market for Stem Cell Suppliers”. According to Mr. Schroeder, “Time to market is the critical driver for shareholders in the pharmaceutical and biotechnology industry. Many delays can be avoided or minimized with an experienced team.” Mr. Schroeder founded CTI fourteen years ago, and is internationally recognized in the field of transplantation and regenerative medicine. During his 30 years in clinical, academic, and industry experience, he has authored more than 200 peer reviewed publications and has presented more than 300 papers at national and international conferences. He has served as a visiting lecturer on more than 200 occasions.
Mr. Schroeder adds, “CTI is happy to be a part of an event involving thought leaders in stem cell and regenerative medicine. Our sponsorship demonstrates our commitment to this field, which will revolutionize the treatment of many diseases, and our appreciation to Dr. Robin Young for leading this groundbreaking conference.”